142 related articles for article (PubMed ID: 36216850)
21. Increased response to cholesterol feeding in apolipoprotein C1-deficient mice.
van Ree JH; Hofker MH; van den Broek WJ; van Deursen JM; van der Boom H; Frants RR; Wieringa B; Havekes LM
Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):905-11. PubMed ID: 7848292
[TBL] [Abstract][Full Text] [Related]
22. Apolipoprotein CI aggravates atherosclerosis development in ApoE-knockout mice despite mediating cholesterol efflux from macrophages.
Westerterp M; Van Eck M; de Haan W; Offerman EH; Van Berkel TJ; Havekes LM; Rensen PC
Atherosclerosis; 2007 Nov; 195(1):e9-16. PubMed ID: 17320883
[TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein C1 stimulates the malignant process of renal cell carcinoma via the Wnt3a signaling.
Jiang H; Tang JY; Xue D; Chen YM; Wu TC; Zhuang QF; He XZ
Cancer Cell Int; 2021 Jan; 21(1):41. PubMed ID: 33430855
[TBL] [Abstract][Full Text] [Related]
24. Constitutive inhibition of plasma CETP by apolipoprotein C1 is blunted in dyslipidemic patients with coronary artery disease.
Pillois X; Gautier T; Bouillet B; Pais de Barros JP; Jeannin A; Vergès B; Bonnet J; Lagrost L
J Lipid Res; 2012 Jun; 53(6):1200-9. PubMed ID: 22474067
[TBL] [Abstract][Full Text] [Related]
25. Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor.
Jong MC; van Dijk KW; Dahlmans VE; Van der Boom H; Kobayashi K; Oka K; Siest G; Chan L; Hofker MH; Havekes LM
Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):281-7. PubMed ID: 10024503
[TBL] [Abstract][Full Text] [Related]
26. Investigation of serum levels and tissue expression of two genes IGFBP-2 and IGFBP-3 act as potential biomarker for predicting the progression and survival in patients with glioblastoma multiforme.
Abdolhoseinpour H; Mehrabi F; Shahraki K; Khoshnood RJ; Masoumi B; Yahaghi E; Goudarzi PK
J Neurol Sci; 2016 Jul; 366():202-206. PubMed ID: 27288807
[TBL] [Abstract][Full Text] [Related]
27. Serum concentrations of glial fibrillary acidic protein (GFAP) do not indicate tumor recurrence in patients with glioblastoma.
Vietheer JM; Rieger J; Wagner M; Senft C; Tichy J; Foerch C
J Neurooncol; 2017 Oct; 135(1):193-199. PubMed ID: 28717884
[TBL] [Abstract][Full Text] [Related]
28. ApoC1 promotes the metastasis of clear cell renal cell carcinoma via activation of STAT3.
Li YL; Wu LW; Zeng LH; Zhang ZY; Wang W; Zhang C; Lin NM
Oncogene; 2020 Sep; 39(39):6203-6217. PubMed ID: 32826950
[TBL] [Abstract][Full Text] [Related]
29. Apolipoprotein c1 association with hepatitis C virus.
Meunier JC; Russell RS; Engle RE; Faulk KN; Purcell RH; Emerson SU
J Virol; 2008 Oct; 82(19):9647-56. PubMed ID: 18667498
[TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein C1: Its Pleiotropic Effects in Lipid Metabolism and Beyond.
Fuior EV; Gafencu AV
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31779116
[TBL] [Abstract][Full Text] [Related]
31. Screening and Identification of APOC1 as a Novel Potential Biomarker for Differentiate of
Li J; Sun L; Xu F; Qi H; Shen C; Jiao W; Xiao J; Li Q; Xu B; Shen A
Front Microbiol; 2016; 7():1961. PubMed ID: 28018301
[No Abstract] [Full Text] [Related]
32. Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing.
Hao X; Zheng Z; Liu H; Zhang Y; Kang J; Kong X; Rong D; Sun G; Sun G; Liu L; Yu H; Tang W; Wang X
Redox Biol; 2022 Oct; 56():102463. PubMed ID: 36108528
[TBL] [Abstract][Full Text] [Related]
33. Both lipolysis and hepatic uptake of VLDL are impaired in transgenic mice coexpressing human apolipoprotein E*3Leiden and human apolipoprotein C1.
Jong MC; Dahlmans VE; van Gorp PJ; Breuer ML; Mol MJ; van der Zee A; Frants RR; Hofker MH; Havekes LM
Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):934-40. PubMed ID: 8696956
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of APOC1 in obob mice leads to hepatic steatosis and severe hepatic insulin resistance.
Muurling M; van den Hoek AM; Mensink RP; Pijl H; Romijn JA; Havekes LM; Voshol PJ
J Lipid Res; 2004 Jan; 45(1):9-16. PubMed ID: 14523051
[TBL] [Abstract][Full Text] [Related]
35. Human apolipoprotein C1 transgenesis reduces atherogenesis in hypercholesterolemic rabbits.
Gautier T; Deckert V; Aires V; Le Guern N; Proukhnitzky L; Patoli D; Lemaire S; Maquart G; Bataille A; Xolin M; Magnani C; Masson D; Harscoët E; Da Silva B; Houdebine LM; Jolivet G; Lagrost L
Atherosclerosis; 2021 Mar; 320():10-18. PubMed ID: 33497863
[TBL] [Abstract][Full Text] [Related]
36. The common insertional polymorphism in the APOC1 promoter is associated with serum apolipoprotein C-I levels in Hispanic children.
Shachter NS; Rabinowitz D; Stohl S; Conde-Knape K; Cohn JS; Deckelbaum RJ; Berglund L; Shea S
Atherosclerosis; 2005 Apr; 179(2):387-93. PubMed ID: 15777558
[TBL] [Abstract][Full Text] [Related]
37. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
Jong MC; Dahlmans VE; van Gorp PJ; van Dijk KW; Breuer ML; Hofker MH; Havekes LM
J Clin Invest; 1996 Nov; 98(10):2259-67. PubMed ID: 8941642
[TBL] [Abstract][Full Text] [Related]
38. Association between APOC1 polymorphism and Alzheimer's disease: a case-control study and meta-analysis.
Zhou Q; Zhao F; Lv ZP; Zheng CG; Zheng WD; Sun L; Wang NN; Pang S; de Andrade FM; Fu M; He XH; Hui J; Jiang W; Yang CY; Shi XH; Zhu XQ; Pang GF; Yang YG; Xie HQ; Zhang WD; Hu CY; Yang Z
PLoS One; 2014; 9(1):e87017. PubMed ID: 24498013
[TBL] [Abstract][Full Text] [Related]
39. Protection from obesity and insulin resistance in mice overexpressing human apolipoprotein C1.
Jong MC; Voshol PJ; Muurling M; Dahlmans VE; Romijn JA; Pijl H; Havekes LM
Diabetes; 2001 Dec; 50(12):2779-85. PubMed ID: 11723061
[TBL] [Abstract][Full Text] [Related]
40. Genetic association study between senile dementia of Alzheimer's type and APOE/C1/C2 gene cluster.
Kamino K; Yoshiiwa A; Nishiwaki Y; Nagano K; Yamamoto H; Kobayashi T; Nonomura Y; Yoneda H; Sakai T; Imagawa M; Miki T; Ogihara T
Gerontology; 1996; 42 Suppl 1():12-9. PubMed ID: 8804993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
